References
- Pfaller MA, Diekem DJ. Epidemiology of invasive Candidiasis: a persistent public health problem. Clin Microbiol Rev Clin Microbiol Rev 2007;20:133–63
- Shapiro RS, Robbins Ni, Cowen LE. Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol Mol Biol Rev 2011;75:213–67
- Mukherjee PK, Sheehan DJ, Hitchcock CA, et al. Combination treatment of invasive fungal infections. Clin Microbiol Rev 2005;18:163–94
- Kathiravan MK, Salake AB, Chothe AS, et al. The biology and chemistry of antifungal agents: a review. Bioorg Med Chem 2012;20:5678–98
- Perlin DS. Resistance to echinocandin-class antifungal drugs. Drug Resist Updat 2007;10:121–30
- Walker LA, Gow NA, Munro CA. Fungal echinocandin resistance. Fungal Genet Biol 2010;47:117–26
- Verweij PE, Snelders E, Kema GH, et al. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis 2009;9:789–95
- Tellam RL, Vuocolo T, Johnson SE, et al. Insect chitin synthase cDNA sequence, gene organization and expression. Eur J Biochem 2000;267:6025–42
- Magellan H, Boccara M, Drujon T, et al. Discovery of two new inhibitors of Botrytis cinerea chitin synthase by a chemical library screening. Bioorg Med Chem 2013;21:4997–5003
- Di Domenico B. Novel antifungal drugs. Curr Opin Microbiol 1999;2:509–15
- Merzendorfer H, Zimoch L. Chitin metabolism in insects: structure, function and regulation of chitin synthases and chitinases. J Exp Biol 2003;206:4393–412
- Grol AH, Lucca AJD, Walsh TJ. Emerging targets for the development of novel antifungal therapeutics. Trends Microbiol 1998;6:117
- Ke S, Liu Fy, Wang N, et al. 1,3,4-Oxadiazoline derivatives as novel potential inhibitors targeting chitin biosynthesis: design, synthesis and biological evaluation. Bioorg Med Chem Lett 2009;19:332–5
- Lenardon MD, MunrCA, Gow NAR. Chitin synthesis and fungal pathogenesis. Curr Opin Microbiol 2010;13:416–23
- Chaudhary PM, Tupe SG, Deshpande MV. Chitin synthase inhibitors as antifungal agents. Mini-Rev Med Chem 2013;13:222–36
- Chen WQ, Dai DF, Wang CC, et al. Genetic dissection of the polyoxin building block-carbamoylpolyoxamic acid biosynthesis revealing the “pathway redundancy” in metabolic networks. Microb Cell Fact 2013;12:121
- Xu WM, Yang S, Bhadury P, et al. Synthesis and bioactivity of novel sulfone derivatives containing 2,4-dichlorophenyl substituted 1,3,4-oxadiazole/thiadiazole moiety as chitinase inhibitors. Pestic Biochem Phys 2011;101:6–15
- Georgopapadakou NH, Tkacz JS. The fungal cell wall as a drug target. Trends Microbial 1995;3:98
- Plant A, Thompson P, Williams DM. Stereoselective synthesis of novel uracil polyoxin C conjugates as substrate analogues of chitin synthase. J Org Chem 2008;73:3714–24
- Yeager AR, Finney NS. Second-generation dimeric inhibitors of chitin synthase. Bioorg Med Chem 2004;12:6451–60
- Chaudhary PM, Chavan SR, Shirazi F, et al. Exploration of click reaction for the synthesis of modified nucleosides as chitin synthase inhibitors. Bioorg Med Chem 2009;17:2433–40
- Renuka N, Kumar KA. Synthesis and biological evaluation of novel formyl-pyrazoles bearing coumarin moiety as potent antimicrobial and antioxidant agents. Bioorg Med Chem Lett 2013;23:6406–9
- Peng XM, Damu GLV, Zhou CH. Current developments of coumarin compounds in medicinal chemistry. Curr Pharm Des 2013;19:3884–930
- Mitra I, Saha A, Roy K. Quantification of contributions of different molecular fragments for antioxidant activity of coumarin derivatives based on QSAR analyses. Can J Chem 2013;91:428–41
- Bansal Y, Sethi P, Bansal G. Coumarin: a potential nucleus for anti-inflammatory molecules. Med Chem Res 2013;22:3049–60
- Keri RS, Hosamani KM, Shingalapur RV, et al. Analgesic, anti-pyretic and DNA cleavage studies of novel pyrimidine derivatives of coumarin moiety. Eur J Med Chem 2010;45:2597–605
- Via LD, Gia O, Magno SM, et al. New tetracyclic analogues of photochemotherapeutic drugs 5-MOP and 8-MOP: synthesis, DNA interaction, and antiproliferative activity. J Med Chem 1999;42:4405–13
- Lee BH, Clothier MF, Dutton FE, et al. Anthel mintic β-hydroxyketoamides (bkas). Bioorg Med Chem Lett 1988;8:3317–20
- Spino C, Dodier M, Sotheeswaran S. Anti-HIV coumarins from calophyllum seed oil. Bioorg Med Chem Lett 1998;8:3475–8
- Hwu JR, Singha R, Hong SC, et al. Synthesis of new benzimidazole–coumarin conjugates as anti-hepatitis C virus agents. Antiviral Res 2008;77:157–62
- Tian LW, Pei Y, Zhang YJ, et al. 7-O-Methylkaempferol and -quercetin glycosides from the whole plant of Nervilia fordii. J Nat Prod 2009;72:1057–60
- Kurdelas RR, Lima B, Tapia A, et al. Antifungal activity of extracts and prenylated coumarins isolated from Baccharis darwinii Hook & Arn. (Asteraceae). Molecules 2010;15:4898–907
- Mladenović M, Vuković N, Nićiforović N, et al. Synthesis and molecular descriptor characterization of novel 4-hydroxy-chromene-2-one derivatives as antimicrobial agents. Molecules 2009;14:1495–512
- Shams HZ, Mohareb RM, Helal MH, Mahmoud AE. Synthesis, structure elucidation, and biological evaluation of some fused and/or pendant thiophene, pyrazole, imidazole, thiazole, triazole, triazine, and coumarin systems based on cyanoacetic 2-[(benzoylamino)thioxomethyl] hydrazide. Phosphorus Sulfur 2007;182:237–63
- Basanagouda M, Shivashankar K, Kulkarni MV, et al. Synthesis and antimicrobial studies on novel sulfonamides containing 4-azidomethyl coumarin. Eur J Med Chem 2010;45:1151–7
- Lucero HA, Kuranda MJ, Bulik DA. A nonradioactive, high throughput assay for chitin synthase activity. Anal Biochem 2002;305:97–105
- Ji QG, Yang D, Wang X, et al. Design, synthesis and evaluation of novel quinazoline-2,4-dione derivatives as chitin synthase inhibitors and antifungal agents. Bioorg Med Chem 2014;22:3405–13
- NCCLS (National Committee for Clinical Laboratory Standards). Performance standards for antimicrobial susceptibility testing: Twelfth informational supplement 2002; M100-S12(M7)